- Previous Close
0.4500 - Open
0.4500 - Bid 0.4600 x --
- Ask 0.4700 x --
- Day's Range
0.4420 - 0.4750 - 52 Week Range
0.1600 - 0.4750 - Volume
222,480 - Avg. Volume
54,522 - Market Cap (intraday)
37.559M - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date Aug 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
www.artrya.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: AYA.AX
View More
Performance Overview: AYA.AX
Trailing total returns as of 10/23/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AYA.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AYA.AX
View MoreValuation Measures
Market Cap
37.56M
Enterprise Value
31.23M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.24
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-34.45%
Return on Equity (ttm)
-59.12%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-14M
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
7.28M
Total Debt/Equity (mrq)
5.65%
Levered Free Cash Flow (ttm)
-7.84M
Company Insights: AYA.AX
AYA.AX does not have Company Insights